Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by harrison99on Mar 04, 2019 9:56pm
147 Views
Post# 29441526

RE:Just bought In

RE:Just bought InYes, a long here, since 2010...still full of hope...for the drug development and the stock price. At these prices, I was able to double down. And the news of all these institutional buyers can only add impetus to the advancement of the drug. Don't forget the earlier institutional buyers at around $15....I believe they are still all in. I'm dreaming of a SP of $50 this year. Let's all hold hands and hummmmmm
<< Previous
Bullboard Posts
Next >>